Cargando…
Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress
Acute myeloid leukemia (AML) is a complex hematological malignancy characterized by extensive heterogeneity in genetics, response to therapy and long-term outcomes, making it a prototype example of development for personalized medicine. Given the accessibility to hematologic malignancy patient sampl...
Autores principales: | Xiang, Wei, Lam, Yi Hui, Periyasamy, Giridharan, Chuah, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910862/ https://www.ncbi.nlm.nih.gov/pubmed/35270002 http://dx.doi.org/10.3390/ijms23052863 |
Ejemplares similares
-
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
por: Granroth, Ginna, et al.
Publicado: (2022) -
Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia()
por: Lam Yi, Hui, et al.
Publicado: (2019) -
Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis
por: Colombo, Anthony R., et al.
Publicado: (2018) -
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges
por: Schlenk, Richard F.
Publicado: (2023) -
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
por: Chuah, Charles, et al.
Publicado: (2009)